A photo of Brian Turpin.

Brian K. Turpin, DO


  • Member, Division of Oncology
  • Associate Professor, UC Department of Pediatrics

About

Biography

Brian K. Turpin, DO, completed his undergraduate training at the University of Missouri, graduate medical training at the Kansas City University of Medicine and Biosciences, and pediatric residency and hematology / oncology fellowship at Cincinnati Children’s Hospital Medical Center where he served as co-chief fellow. 

Dr. Turpin’s clinical and academic interests pertain to children and young adults with solid tumors, particularly sarcomas and neuroblastomas, with a research focus on the development of new drugs and clinical trials for patients with relapsed cancer.

Locations (2)

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B. Pediatric Blood and Cancer. 2021.

Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms. Sabnis, HS; Shulman, DS; Mizukawa, B; Bouvier, N; Zehir, A; Fangusaro, J; Fabrizio, VA; Whitlow, C; Winchester, M; Agresta, L; et al. Journal of Clinical Oncology. 2021; 39:3822-3828.

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies. Brohl, AS; Sindiri, S; Wei, JS; Milewski, D; Chou, HC; Song, YK; Wen, X; Kumar, J; Reardon, HV; Mudunuri, US; et al. Cell Reports. 2021; 37.

FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma. Milewski, D; Shukla, S; Gryder, BE; Pradhan, A; Donovan, J; Sudha, P; Vallabh, S; Pyros, A; Xu, Y; Barski, A; et al. Oncogene. 2021; 40:2182-2199.

Reply to comment on: Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Turpin, B; Todd, KE; Pressey, JG. Pediatric Blood and Cancer. 2020; 67.

Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Todd, K; Kim, HK; Szabo, S; Johnson, S; Pressey, J; Nagarajan, R; Sorger, J; Dasgupta, R; Turpin, B. Pediatric Blood and Cancer. 2020; 67.

Can a children's hospital still cut it? Comparing outcomes of pediatric, adolescent and young adult patients undergoing thoracic surgery for lung metastases. Scorletti, F; Cooke-Barber, J; Pressey, JG; Nagarajan, R; Turpin, B; Jenkins, T; Dasgupta, R. Pediatric Blood and Cancer. 2020; 67.

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung. Baird, K; Glod, J; Steinberg, SM; Reinke, D; Pressey, JG; Mascarenhas, L; Federman, N; Marina, N; Chawla, S; Lagmay, JP; et al. Sarcoma. 2020; 2020.

Paediatric ganciclovir dosing in extracorporeal membrane oxygenation: Is standard dosing good enough?. Murphy, M; Chamberlain, A; Tang, P; Turpin, B; Danziger-Isakov, L. Journal of Clinical Pharmacy and Therapeutics. 2020; 45:218-220.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey